BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 206531)

  • 1. Paradoxical effect of mecillinam on Providencia stuartii.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1976 Dec; 2(4):386-8. PubMed ID: 206531
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of mecillinam and mecillinam/ampicillin combinations on Proteus species.
    Hone R; Foley M
    J Antimicrob Chemother; 1980 May; 6(3):410-2. PubMed ID: 6249783
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the effect of mecillinam upon Micrococcaceae and faecal streptococci under conditions simulating urinary tract infection.
    Anderson JD; Adams MA; Wilson LC; Shepherd CA
    J Antimicrob Chemother; 1976 Dec; 2(4):351-61. PubMed ID: 206530
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model.
    Anderson JD; Eftekhar F; Cleeland R; Kramer MJ; Beskid G
    J Antimicrob Chemother; 1981 Aug; 8(2):121-31. PubMed ID: 6268599
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
    Neu HC
    Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
    Stille W; Bischof-Léger E; Helm EB
    Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of Enterobacteriaceae isolated from humans to 6-N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX)].
    Zaremba M; Zukowska-Nytko K; Grala-Kałuzna A; Kacprzak-Wiatr A; Piotrowski J; Kulikowska A; borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):17-26. PubMed ID: 6292593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibacterial activity of mecillinam against E. coli isolated from urinary tract infections (author's transl)].
    Shimizu Y
    Jpn J Antibiot; 1981 Jul; 34(7):1087-91. PubMed ID: 6275141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy and mecillinam.
    Gray J
    J Antimicrob Chemother; 1977 Nov; 3(6):531-3. PubMed ID: 202586
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
    Kocka FE; Srinivasan S; Mowjood M; Kantor HS
    J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains.
    Taylor PW; Gaunt H; Unger FM
    Antimicrob Agents Chemother; 1981 May; 19(5):786-8. PubMed ID: 6271047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mecillinam.
    Bakhtiar M; Selwyn S
    Lancet; 1978 Feb; 1(8059):337. PubMed ID: 75379
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro sensitivity to mecillinam of multiresistant gram-negative rods.
    Chattopadhyay B; Thomas E
    Lancet; 1978 Jan; 1(8057):214-5. PubMed ID: 74642
    [No Abstract]   [Full Text] [Related]  

  • 17. Kanamycin resistance in Providencia stuartii.
    McHale P; English L; Speekenbrink A; Keane C
    J Antimicrob Chemother; 1978 May; 4(3):273-8. PubMed ID: 670120
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of mecillinam against anaerobic bacteria.
    Steinkraus GE; McCarthy LR
    Antimicrob Agents Chemother; 1980 Jun; 17(6):954-6. PubMed ID: 6250471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pefloxacin on adherence of Proteus-Providencia spp to squamous epithelial cells.
    Cellini L; Piccolomini R; Allocati N; Di Girolamo A; Catamo G
    Chemioterapia; 1988 Oct; 7(5):298-301. PubMed ID: 3224397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro activity of mecillinam with other antimicrobial chemotherapeutic agents against Salmonella Shigella and El Tor Vibrio cholerae.
    Mhalu FS; Swai V; Runyoro D; Shao JF
    East Afr Med J; 1982 Oct; 59(10):676-81. PubMed ID: 6309499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.